Form 4: Encompass Health EVP Acquires Stock Options

Sentiment:

SEC Form 4


John Patrick Darby, EVP, Gen Counsel & Secretary of Encompass Health Corp, reports acquisition of stock options.

Summary

  • John Patrick Darby, an Executive Vice President, General Counsel, and Secretary at Encompass Health Corp, filed a Form 4.
  • The form reports a transaction on March 4, 2025, where Darby acquired 6,032 non-qualified stock options with an exercise price of $98.45.
  • These options become exercisable in equal annual installments over a three-year period starting March 4, 2026.
  • Following the reported transaction, Darby directly owns 6,032 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of stock options can be seen as a slightly positive sign, indicating confidence, but it's not a major event.

Positives

  • The acquisition of stock options by a high-ranking executive could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that a key executive is incentivized through stock options, which is a common practice in the healthcare industry.

Comparison to Industry Standards

  • Stock option grants are a common form of executive compensation in the healthcare industry.
  • Companies like HCA Healthcare and Universal Health Services also utilize stock options as part of their executive compensation packages.
  • The vesting schedule and exercise price are typical for such grants.

Stakeholder Impact

  • The acquisition of stock options by an executive could have a minor positive impact on shareholder sentiment, as it aligns management's interests with those of the shareholders.

Key Dates

DateDescription
03/04/2025Date of transaction: Acquisition of stock options.
03/04/2026First vesting date: Options become exercisable in equal annual installments over a three-year period commencing on this date.
03/04/2035Expiration date of the stock options.
03/05/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.